SERUM MARKERS AND CYTOKINES IN PATIENTS WITH OVARIAN CANCER, ENDOMETRIOSIS OR OTHER BENIGN OVARIAN TUMOURS

被引：0
|
作者：
Nowak, Marek [1 ]
Misiek, Marcin [2 ]
Janas, Lukasz [1 ]
Piwowarczyk, Iwona [1 ]
Soja, Malwina [1 ]
Masternak, Martyna [1 ]
Glowacka, Ewa [3 ]
Kielbik, Michal [4 ]
Szulc-Kielbik, Izabela [4 ]
Klink, Magdalena [4 ]
机构：
[1] Polish Mothers Mem Hosp Res Inst, Dept Operat Gynecol & Gynecol Oncol, Lodz, Poland
[2] Holy Cross Canc Ctr, Dept Gynaecol, Calgary, AB, Canada
[3] Polish Mothers Mem Hosp Res Inst, Lab Diagnost Ctr, Lodz, Poland
[4] Polish Acad Sci, Inst Med Biol, Warsaw, Poland
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2020年 / 30卷
关键词：
D O I：
10.1136/ijgc-2020-ESGO.109
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
264
引用
收藏
页码：A60 / A60
页数：1
相关论文
共 50 条
  • [1] Benign epithelial ovarian tumours - cancer precursors or markers for ovarian cancer risk?
    Jordan, S
    Green, A
    Webb, P
    [J]. CANCER CAUSES & CONTROL, 2006, 17 (05) : 623 - 632
  • [2] Benign Epithelial Ovarian Tumours—cancer Precursors or Markers for Ovarian Cancer Risk?
    Susan Jordan
    Adèle Green
    Penelope Webb
    [J]. Cancer Causes & Control, 2006, 17 : 623 - 632
  • [3] Changes in tumor markers, coagulation function and serum VEGF in patients with ovarian cancer and benign ovarian disease
    Wang, Jiaying
    Zhu, Miaohua
    Zhou, Xiaoming
    Wang, Tingting
    Zhang, Jing
    [J]. JOURNAL OF BUON, 2020, 25 (05): : 2287 - 2292
  • [4] Venous Thromboembolic Complications in Patients with Ovarian Cancer compared to Patients with Benign Ovarian Tumours
    Kahr, H. Strom
    Knudsen, A.
    Christiansen, O. B.
    Grove, A.
    Iyer, V.
    Thorlacius-Ussing, O.
    [J]. THROMBOSIS RESEARCH, 2018, 164 : S215 - S215
  • [5] Venous Thromboembolic Complications in Patients with Ovarian Cancer compared to Patients with Benign Ovarian Tumours
    Kahr, H. S.
    Knudsen, A.
    Christiansen, O. B.
    Grove, A.
    Iyer, V.
    Thorlacius-Ussing, O.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 738 - 738
  • [6] SERUM CHEMOKINE LEVELS IN PATIENTS WITH OVARIAN CANCER OR BENIGN OVARIAN CYSTS
    Nowak, M.
    Glowacka, E.
    Janas, L.
    Wilczynski, J. R.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1458 - 1458
  • [7] Proinflammatory and immunosuppressive serum, ascites and cyst fluid cytokines in patients with early and advanced ovarian cancer and benign ovarian tumors
    Nowak, Marek
    Glowacka, Ewa
    Szpakowski, Marian
    Szyllo, Krzysztof
    Malinowski, Andrzej
    Kulig, Andrzej
    Tchorzewski, Henryk
    Wilczynski, Jan
    [J]. NEUROENDOCRINOLOGY LETTERS, 2010, 31 (03) : 375 - 383
  • [8] COORDINATE ELEVATION OF SERUM MARKERS IN OVARIAN-CANCER BUT NOT IN BENIGN DISEASE
    BAST, RC
    KNAUF, S
    EPENETOS, A
    DHOKIA, B
    DALY, L
    TANNER, M
    SOPER, J
    CREASMAN, W
    GALL, S
    KNAPP, RC
    ZURAWSKI, VR
    SCHLOM, J
    KUFE, DW
    RITTS, RE
    [J]. CANCER, 1991, 68 (08) : 1758 - 1763
  • [9] COORDINATE ELEVATION OF SERUM MARKERS IN OVARIAN-CANCER BUT NOT IN BENIGN DISEASE
    BAST, RC
    KNAUF, S
    EPENETOS, A
    TANNER, M
    KLUG, T
    SOPER, J
    CREASMAN, W
    GALL, S
    KNAPP, RC
    ZURAWSKI, V
    SCHLOM, J
    KUFE, D
    RITTS, RE
    [J]. HYBRIDOMA, 1987, 6 (02): : 235 - 235
  • [10] COORDINATE ELEVATION OF SERUM MARKERS IN OVARIAN-CANCER BUT NOT IN BENIGN DISEASE
    BAST, RC
    KNAUF, S
    EPENETOS, AA
    TANNER, M
    KLUG, T
    SOPER, J
    CREASMAN, W
    GALL, S
    KNAPP, RC
    ZURAWSKI, V
    SCHLOM, J
    KUFE, D
    RITTS, RE
    [J]. BRITISH JOURNAL OF CANCER, 1987, 56 (04) : 509 - 510
12345